Zentalis Pharmaceuticals (ZNTL) Change in Receivables (2019 - 2025)
Zentalis Pharmaceuticals (ZNTL) recorded quarterly Change in Receivables of -$5.0 million in Q1 2025, down 200.0% quarter-over-quarter from $5.0 million in Q4 2024.
Zentalis Pharmaceuticals (ZNTL) Change in Receivables (2019 - 2025) Analysis & Trends
Zentalis Pharmaceuticals' Change in Receivables history runs 6 years deep, the most recent figure standing at -$5.0 million for Q1 2025.
- In Q1 2025, Change in Receivables changed N/A year-over-year to -$5.0 million; the TTM figure through Dec 2025 stood at -$5.0 million (down 200.0% YoY), while the FY2025 annual figure was -$5.0 million, down 200.0% from the prior year.
- Change in Receivables was -$5.0 million for Q1 2025 at Zentalis Pharmaceuticals, down from $5.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $5.0 million in Q4 2024 to a low of -$5.0 million in Q1 2025.
- Historically, Change in Receivables has averaged -$58428.6 across 4 years, with a median of -$104000.0 in 2021.
- Biggest YoY gain for Change in Receivables was 110.2% in 2021; the steepest drop was 16800.0% in 2021.
- A 4-year view of Change in Receivables shows it stood at -$104000.0 in 2021, then surged by 103.85% to $4000.0 in 2022, then soared by 124900.0% to $5.0 million in 2024, then tumbled by 200.0% to -$5.0 million in 2025.
- The last three Change in Receivables figures came in at -$5.0 million (Q1 2025), $5.0 million (Q4 2024), and $4000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -4.08 Mn |
| 10 | Zentalis Pharmaceuticals | 264.90 Mn | 264.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5.00 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2021 | -104,000.00 |
| Dec 31, 2021 | -104,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Jun 30, 2021 | -243,000.00 |
| Jun 30, 2021 | -243,000.00 |
| Mar 31, 2021 | -169,000.00 |
| Mar 31, 2021 | -169,000.00 |
| Dec 31, 2020 | 295,000.00 |
| Dec 31, 2020 | 295,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | -66,000.00 |
| Jun 30, 2020 | -66,000.00 |